Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FBAJ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,852
Award facts
- Contract value 100% obligated
- $39,851.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $39,851.98. This is a firm fixed price delivery order with an ultimate completion date of June 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Dupixent (dupilumab) is a specialty pharmaceutical used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, reflecting the Defense Health System's need for advanced biologic medications.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp has demonstrated capability to meet the Defense Health System's specialized pharmaceutical requirements through this flexible contracting mechanism, which allows for efficient fulfillment of discrete medical supply needs across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FBAJ1?
SPE2DB25FBAJ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 25, 2025.
How much is contract SPE2DB25FBAJ1 worth?
The government has obligated $39,852 on SPE2DB25FBAJ1.
Is contract SPE2DB25FBAJ1 an order under another contract?
Yes. SPE2DB25FBAJ1 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBAJ1 competed?
The extent of competition for SPE2DB25FBAJ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award